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There is mounting clinical and experimental evidence that intermittent, 
hypoxic conditioning (IHC) is cardioprotective, especially in models of myocar­
dial ischemia -  reperfusion (IR) [1-8]. The current investigation tested the 
hypothesis that moderate, normobaric, intermittent hypoxia is both cardioprotec­
tive and vasoprotective in a rat model of myocardial IR.
Methods. Wistar rats weighing 250-280 g were subjected to normobaric 
IHC in a hypoxic chamber (5-8 cycles/d for 20 days, F I02 9.5 - 10% for 5 - 10 
min/cycle, with intervening 4 min normoxia), a regimen that may have clinical 
applications. Control rats were sham-conditioned with 21% Ог-
One day after completing the IHC conditioning program (n=14) or the 
sham conditioning program (n=14), rats were anesthetized with urethane and 
placed on artificial respiration, ECG leads were attached, and the chest was 
opened. After a 30-min stabilization period, the main left coronary artery (LCA) 
was ligated for 30 min followed by 60-min reperfusion, while arrhythmias were 
monitored. Myocardial ischemia during LCA ligation was confirmed by regional 
cyanosis and progressive, marked ST segment elevation. Reperfusion was con­
firmed by an epicardial hyperemic response. When ventricular fibrillation oc­
curred, the time to spontaneous defibrillation was measured.
Infarct size (IS) was evaluated with the triphenyl-tetrazolium chloride 
(TTC)-Evans blue technique. After 60 min o f coronary reperfusion, the hearts 
were excised, perfused with 2% Evans blue dye to separate the left ventricular 
area at risk for infarction (AAR; tissue distal to the LCA ligature) from sur­
rounding normal tissue (stained blue). The heart was then frozen at -20°C for 20 
min, and cut into 5 2-mm-thick transverse slices. The slices were incubated for 
20 min at 37°C in a 1% solution o f TTC in phosphate buffer (pH=7.4) to differ­
entiate the infarcted area (pale) from the non-infarcted AAR (red). Slices were 
fixed in a 10% formaldehyde solution, and photographed. The corresponding ar­
eas were measured by computerized planimetry, and infarct size was calculated 
as a percentage of the AAR.
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In addition to parameters of cardioprotection, endothelial dysfunction was 
evaluated as an index of vasoprotective effects o f IHC. Endothelium-dependent 
relaxation (EDR) was evaluated by the dilatory response to acetylcholine (10 
цМ) of norepinephrine (0.5 |iM)-precontracted, isolated aortic rings from 
control and IHC rats with and without IR.
In all figures, * indicates a statistically significant difference (p<0.05) 
between IHC and Control.
Results. The 20-day normobaric hypoxic training did not induce any sig­
nificant changes in the relative weight of right ventricle (Table 1), thus mitigat­
ing concerns about hypoxia-induced right ventricular hypertrophy.
Table 1 - Effect of IHC on the relative weight of right ventricle.
BW RVW/(RVW+LVW) RVW/BW
Control 314 + 31 0.23 + 0.03 0.00061 +0.00008
IHC 342+ 16 0.22 + 0.03 0.00064 + 0.00008
Values are means±SE from 14 animals per experimental group. BW = body 
weight, g; RVW = right ventricle weight, g; LVW = left ventricle weight, g 
Total durations of ischemic extrasystole, ventricular tachycardia and ventricular 
fibrillation were significantly shorter in rats adapted to intermittent hypoxia than 
in untreated animals (Figure 1). However no protection against reperfusion ar­
rhythmias was observed; the duration of reperfusion arrhythmias did not differ 
in hypoxia-adapted and non-adapted animals. The same was true for the occur­
rence of arrhythmias. All types of arrhythmias occurred less frequently in 
adapted than in control rats during ischemia (Figure 2). The proportion of rats 
with reperfusion arrhythmias was similar in control and IHC rats.
Extrasystole Ventricular Ventricular 
tachycardia fibrillation
Fig. 1. Effect of IHC on duration of arrhythmias during ischemia. Light bars, 
control; dark bars, IHC. ‘Significantly different from control, p <0.05.
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Extrasystole Ventricular Ventricular 
tachycardia fibrillation
Fig. 2. Effect of IHC on occurrence (% of total experiments) of arrhythmias during ischemia. 
Light bars, control; dark bars, IHC. *Significantly different from control, p <0.05.
Area at risk Infarct size
IHT Control
Fig 3. Effect of IHC on infarct size (Panel A) and area at risk (Panel B). Panel A: Light bars, 
control; dark bars, IHC. ‘Significantly different from control, p <0.05 Panel B: light 
segments, infarct zone; dark segments, non-infarcted area at risk.
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Control IHC IR IHC+IR
Fig. 4. Effect of prior IHC treatment on endothelium-dependent relaxation of isolated rat 
aorta following myocardial ischemia and reperfusion (IR). Values are percentage of 
pre-ACH treatment diameter.‘Significantly different from control, p <0.05. 
‘Significantly different from IR, p <0.05
Figure 3 illustrates the infarct size and area at risk (AAR) determined after
1 hr o f reperfusion. In non-adapted rats, infarct size was almost twice as large as 
in control and constituted 30.6+4.6% o f AAR, while in IHC rats, infarct size was 
only 17.7±3.5% of AAR (p<0.05). AARs did not significantly differ in IHC and 
control animals.
In aortic rings of Control animals, ACH caused a 46% increased in diame­
ter of the pre-contracted rings. Figure 4 shows that IHC alone reduced pre- 
ischemic EDR to 33.9±3.3% (p<0.05 vs. control). Ischemia and reperfusion 
induced pronounced endothelial dysfunction but this disorder was completely 
prevented by prior IHC (29.9±2.9% after IR).
Discussion. Intermittent hypoxic conditioning (IHC) has been used for preven­
tion and treatment of many diseases, including bronchial asthma, allergic neu­
rodermatitis, hypertension, diabetes mellitus, Parkinson’s disease, emotional 
disorders, dyslipidemia, paranoid form o f schizophrenia, radiation toxicity, cer­
tain occupational diseases; and in sports [9]. The basic mechanisms underlying 
the beneficial effects o f IHC, specifically IHC-induced cardioprotection are not 
completely understood but IHC is known to induce gene expression of protec­
tive proteins, stimulate antioxidant defenses, stabilize cell membranes, modulate 
NO synthesis, activate ATP-sensitive K+ channels, prevent Ca‘+ overload of 
cells, improve 0 2 transport in tissues, and increase efficiency o f oxygen utiliza­
tion in ATP production [4-6, 8-10].
In clinical studies IHC showed a high anti-arrhythmic and anti-anginal ef­
ficacy in patients with ischemic heart disease, which exceeded the efficacy of 
drug therapy. An advantage o f IHC over drug therapy is in the fact that IHC nei­
ther suppressed myocardial contractility nor impaired heart conductance and
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provided more stable and long-term effect than anti-arrhythmic and anti-anginal 
medication [7,11].
Experimental data obtained in the present study support the clinical appli­
cation of the IHC method and demonstrate that IHC exerts not only anti- 
arrhythmic but also cell-protective and vasoprotective effects in the heart ex­
posed to ischemia and reperfusion.
We recently proposed that IHC may suppress acute NO overproduction 
and oxidative stress during IR [8]. This mechanism may also protect both coro­
nary and non-coronary blood vessels from the oxidative stress associated with 
IR [13-15]. Adaptive increases in antioxidant enzyme activities may also be 
protective [15].
Conclusions.
• Intermittent hypoxic preconditioning (IHC) protects rat heart against 
ischemic arrhythmias including extrasystole, ventricular tachycardia and ven­
tricular fibrillation.
• IHC decreases the size o f infarct zone formed after ischemia and reper- 
fusion but does not influence the area at risk.
• IHC prevents aortic endothelial dysfunction after myocardial ischemia 
and reperfusion.
• Moderate, intermittent, normobaric hypoxia conditioning is both 
cardio- and vasoprotective in a rat model o f myocardial IR.
Our positive findings may encourage clinical applications o f this novel, 
non-invasive approach to protecting myocardium and vasculature threatened by 
ischemia and reperfusion.
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ДИСФУНКЦИЯ ЭНДОТЕЛИЯ И КИСЛОРОДСВЯЗЫ ВАЮ Щ ИЕ 
СВОЙСТВА ГЕМ ОГЛОБИНА 
Зинчук В.В.
У О «Гродненский государственный медицинский университет»,
Беларусь
Данные современной фундаментальной и клинической медицины 
указывают на то, что при заболеваниях сердечно-сосудистой системы од­
ним из наиболее вероятных мест повреждения организма является эндоте­
лий сосудистой стенки. В течение последних десятилетий кардинальным 
образом пересматриваются представления о его физиологической роли в 
организме. Эндотелий является не просто структурным обрамлением сосу­
дов, а функционально активным органом с набором разнообразных функ­
ций. Его значимость иллюстрируется известной фразой J. Vane «Эндоте­
лий -  маэстро сердечно-сосудистой системы», а также названием актовой 
речи авторитетного исследователя по фармакотерапии эндотелия профес­
сора Р. Григлевского «Эндотелий и моя жизнь» при присуждении ему зва­
ния Почетного Доктора Гродненского медицинского университета. В кли­
